Excessive Pricing in Pharmaceutical Markets: A Review of the Legal Test for Competition Authorities

2021 ◽  
Author(s):  
Tim van Helfteren
Keyword(s):  
Pharmaceutical Markets ◽  
Legal Test

MARKETING AUTHORIZATION OF GENERIC DRUG: GLOBAL ISSUE AND CHALLENGES

2013 ◽  
Vol 1 (3) ◽  
pp. 1-6
Author(s):  
Pankaj Kashyap ◽  
Eshant Duggal ◽  
Parveen Budhwar ◽  
Jitendra Kumar Badjatya
Keyword(s):  
Generic Drug ◽  
Patent Protection ◽  
Drug Approval ◽  
Approval Process ◽  
Generic Medicines ◽  
Healthcare Provision ◽  
Pharmaceutical Markets ◽  
Global Issue ◽  
Drug Approval Process ◽  
High Level

Generic medicines are those whose patent protection has expired, and which may be produced by manufacturers otherthan the innovator company. Use of generic medicines has been increasing in recent years, primarily as a cost savingmeasure in healthcare provision. Generic medicines are typically 20 to 90% cheaper than originator equivalents. Theobjective is to provide a high-level description of what generic medicines are and how they differ, at a regulatory andlegislative level, from originator medicines. It describes the current and historical regulation of medicines in theworld’s two main pharmaceutical markets, in addition to the similarities, as well as the differences, between genericsand their originator equivalents including the reasons for the cost differences seen between originator and genericmedicines. This article refers to the general generic drug approval process in India, USA, and Japan. They havedifferent regulation and approval process. 

Strategies of stratification: Regulating market access in the era of personalized medicine

2021 ◽  
pp. 030631272110055
Author(s):  
Sarah Wadmann ◽  
Amalie Martinus Hauge
Keyword(s):  
Personalized Medicine ◽  
Patient Population ◽  
Science And Technology Studies ◽  
Market Access ◽  
European Medicines Agency ◽  
The Political ◽  
Market Regulation ◽  
Publicly Funded ◽  
Pharmaceutical Markets ◽  
Danish Healthcare System

Personalized medicine raises the stakes of pharmaceutical market regulation. Drawing on pragmatist valuation studies and science and technology studies literature on personalized medicine and pharmaceutical markets, this article demonstrates how complex negotiations about the value of a pharmaceutical can constitute a market in various ways, while also shaping the concerned patient populations. Tracing the path of a pharmacogenetic treatment, Spinraza, from its approval by the European Medicines Agency to its adoption in the publicly funded Danish healthcare system, we show how the market was formatted through particular stratifications of the patient population. We conceptualize these seemingly technical moves as strategies of stratification, that is, the application of techniques to assemble and divide data – and what data are meant to represent – into groups delineated by certain characteristics. We argue that stakeholders’ use of strategies of stratification has important implications not only for market access, but also for the delineation of diseases and patient populations. Hence, it is crucial to make intelligible the mutual constitution of pharmaceutical markets and patient populations and the political efforts of delineating and connecting the two.

scholarly journals SCREENING AND CONFIRMATION OF DIFFERENT SYNTHETIC ADULTERANTS IN SLIMMING PRODUCTS

2018 ◽  
Vol 11 (2) ◽  
pp. 260 ◽  
Author(s):  
Sajad Fakhri ◽  
Bahareh Mohammadi ◽  
Ronak Jalili ◽  
Marziyeh Hajialyani ◽  
Gholamreza Bahrami
Keyword(s):  
Mass Spectrometry ◽  
Liquid Chromatography ◽  
Reliable Method ◽  
Health It ◽  
Public Authorities ◽  
Herbal Products ◽  
Pharmaceutical Markets ◽  
Synthetic Drugs ◽  
World Markets

 Objective: The presence of synthetic drugs (as adulterant) in slimming herbal products of world markets has contravened the country’s law and has created many troubles for some consumers of slimming products. This study aims to use a simple and reliable method for simultaneously finding and validating the presence of possible adulterants in some slimming products, which could not be discriminated due to misleading packaging.Method: Fifteen slimming products were obtained from the Iran pharmaceutical markets. Liquid chromatography-ultraviolet and LC-mass spectrometry methods were performed for simultaneous screening and confirmation of adulterants.Results: The most abundant adulterant was Phenolphthalein, which has been used in 11 cases of the 15 slimming products. Furthermore, 5 products included caffeine, two included phendimetrazine, and two included protriptyline.Conclusion: The performed method was successful in detection of different adulterants. According to the presence of synthetic drugs in slimming herbal products, and their threats to people’s health it is necessary to create awareness in this case through public authorities.

scholarly journals Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs

2003 ◽  
Vol 51 (2) ◽  
pp. 243-270 ◽  
Author(s):  
Ernst R. Berndt ◽  
Robert S. Pindyck ◽  
Pierre Azoulay
Keyword(s):  
Consumption Externalities ◽  
Pharmaceutical Markets ◽  
Antiulcer Drugs ◽  
And Diffusion
Sign in / Sign up

Export Citation Format

Share Document